Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - TME Pharma NV - Minutes of the TME Pharma Annual General Meeting
Minutes of the TME Pharma Annual General Meeting
GlobeNewswire

Minutes of the TME Pharma Annual General Meeting Berlin, Germany, June 17, 2026, 6:30 p.m. CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for…

fool.com - Josh Kohn-Lindquist - Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
The Motley Fool

iShares U.S. Pharmaceuticals ETF (IHE 0.86%) offers a more stable, dividend-focused path into healthcare compared to the high-volatility, equal-weighted growth profile of the State Street SPDR S&P Biotech ETF (XBI +2.91%). Both funds launched in…

fool.com - Brendan Coffey - Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum
Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum
The Motley Fool

Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price gains. On June 9, 2026, Director Robert Mashal reported the acquisition of 25,000 shares of Nuvation Bio (NUVB…

forbes.com - Amy Feldman - The Healthcare M&A Wave
The Healthcare M&A Wave
Forbes

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here. Pharmaceutical M&A reached $65 billion in the first quarter, its highest number since 2020…

thehindubusinessline.com - India bans OTC cough syrups; Rs 5,700 crore pharma segment faces volume pressure
India bans OTC cough syrups; Rs 5,700 crore pharma segment faces volume pressure
BusinessLine

The cough and cold liquids market of the Indian Pharmaceutical Industry, valued at approximately Rs 5,700 crore, faces a serious risk of volume decline as the Indian government banned over-the-counter (OTC) sales of all syrups, including cough…

pehub.com - John R Fischer - How a decade of pharma digitalization drove Nordic's $8.9 bn sale of Clario to Thermo Scientific
How a decade of pharma digitalization drove Nordic's $8.9 bn sale of Clario to Thermo Scientific
PE Hub

A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.

marketbeat.com - BridgeBio Pharma, Inc. $BBIO Shares Sold by Granahan Investment Management LLC
BridgeBio Pharma, Inc. $BBIO Shares Sold by Granahan Investment Management LLC
MarketBeat

Granahan Investment Management LLC lowered its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 36.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm…

globenewswire.com - Orion Oyj - Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire

STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…

heraldnet.com - Will Geschke - Everett city attorney to retire Aug. 15
Everett city attorney to retire Aug. 15
HeraldNet.com

Published 1:08 pm Wednesday, June 17, 2026 EVERETT — The city of Everett's lead attorney will retire, the city announced in a press release Thursday. David Hall, who has served in the city attorney's office since 2008, helped file the city's…

seekingalpha.com - Franklin Templeton - ClearBridge Appreciation Fund Q1 2026 Commentary (SHAPX)
ClearBridge Appreciation Fund Q1 2026 Commentary (SHAPX)
Seeking Alpha

The ClearBridge Appreciation Fund performed better than the benchmark S&P 500 Index in the first quarter of 2026, with positive contributions from five of 11 sectors. ASML share performance was primarily fueled by record-breaking orders for AI…

afaqs.com - Anushka Jha - How Truecaller's new feature turns every call into a shopping shortcut
How Truecaller's new feature turns every call into a shopping shortcut
afaqs!

As telecom operators and smartphone makers increasingly offer caller identification and spam protection features, Truecaller is betting that its next phase of growth lies not just in identifying calls but in monetising the moments around them.

cyclingnews.com - Patrick Fletcher - Tour of Slovenia: Laurence Pithie wins by a country mile in Red Bull 1-2 on stage 1
Tour of Slovenia: Laurence Pithie wins by a country mile in Red Bull 1-2 on stage 1
Cyclingnews

Laurence Pithie sprinted to a resounding victory on the opening day of the Tour of Slovenia in a 1-2 finish for Red Bull-Bora-Hansgrohe. The New Zealander opened up such a big gap on his rivals in the final dash to the line that his own lead-out…

forbes.com - Jason Kirsch - 5 Best Dividend Stocks To Buy For July 2026
5 Best Dividend Stocks To Buy For July 2026
Forbes

Woman examines the changes in the stock market at her office. The best dividend stocks to buy for July were selected by analyzing yield sustainability, dividend growth over time and fundamental business quality. The first half of 2026 has tested…

businessinsider.com - Ben Bergman - Allbirds is now Smartbirds, and its AI-focused CEO says people won't even remember the shoes
Allbirds is now Smartbirds, and its AI-focused CEO says people won't even remember the shoes
Business Insider

A few years ago, Allbirds was Silicon Valley's favorite sneaker company. Now it's betting its future on AI infrastructure. After selling off its footwear business and shedding most of its workforce, the company formerly known for its eco-friendly…

news-medical.net - AI-designed drug for Parkinson's begins first human trial
AI-designed drug for Parkinson's begins first human trial
News-Medical

Insilico Medicine ('Insilico', HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration with Hygtia…

Receive a Daily briefing on Pharma Industry News

Get Started